共 37 条
- [1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
- [3] USEFULNESS OF RECANALIZATION TO LUMINAL DIAMETER OF 0.6 MILLIMETER OR MORE WITH INTRACORONARY STREPTOKINASE DURING ACUTE MYOCARDIAL-INFARCTION IN PREDICTING NORMAL PERFUSION STATUS, CONTINUED ARTERIAL PATENCY AND SURVIVAL AT ONE YEAR [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (06) : 519 - 522
- [5] CANNON CP, 1994, ACTA CARDIOL, V49, P1
- [6] A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) : 993 - 1003
- [7] COMPARISON OF FRONT-LOADED RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, ANISTREPLASE AND COMBINATION THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) 4 TRIAL [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (07) : 1602 - 1610